KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Interest & Investment Income (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Interest & Investment Income for 11 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 52.78% year-over-year to $3.7 million, compared with a TTM value of $12.8 million through Dec 2025, down 48.87%, and an annual FY2025 reading of $12.8 million, down 48.87% over the prior year.
  • Interest & Investment Income was $3.7 million for Q4 2025 at Medpace Holdings, up from $1.5 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $7.9 million in Q4 2024 and bottomed at -$1.6 million in Q3 2022.
  • Average Interest & Investment Income over 5 years is $1.7 million, with a median of $20000.0 recorded in 2021.
  • The sharpest move saw Interest & Investment Income crashed 3763.41% in 2022, then skyrocketed 7269.52% in 2024.
  • Year by year, Interest & Investment Income stood at -$23000.0 in 2021, then tumbled by 3495.65% to -$827000.0 in 2022, then skyrocketed by 322.97% to $1.8 million in 2023, then surged by 327.49% to $7.9 million in 2024, then tumbled by 52.78% to $3.7 million in 2025.
  • Business Quant data shows Interest & Investment Income for MEDP at $3.7 million in Q4 2025, $1.5 million in Q3 2025, and $1.1 million in Q2 2025.